Get access

Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor

Authors

  • Kira L. Epstein DVM, DACVS,

    1. Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602,
    Search for more papers by this author
  • Benjamin M. Brainard VMD, DACVECC, DACVA,

    1. Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, and
    Search for more papers by this author
  • Marco A.F. Lopes MV, PhD,

    1. Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602,
    Search for more papers by this author
  • Michelle H. Barton DVM, PhD, DACVIM,

    1. Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602,
    2. Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602
    Search for more papers by this author
  • James N. Moore DVM, PhD

    1. Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602,
    2. Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602
    Search for more papers by this author

  • Conflict of interest: none
    Portions of these data were previously presented in poster form at the 2008 ACVIM Symposium, San Antonio, TX, June 4–7, 2008.

  • Funding received from: University of Georgia Clinical Research Grant, Georgia Veterinary Scholars Program (Merck/Merial).

Address correspondence and reprint requests to
Dr. Kira L. Epstein, Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USA. Email: kirae@uga.edu

Abstract

Objectives – To develop a standardized technique for thrombelastography (TEG) analysis in healthy adult horses, with and without the ex vivo addition of tissue factor (TF) as an activator. To determine reference intervals for TEG parameters in the horse, and to determine if traditional coagulation tests correlate with TEG.

Design – Prospective, observational.

Setting – Veterinary teaching hospital.

Animals – Twenty-six healthy adult horses.

Interventions – None.

Measurements and Main Results – Thrombelastography with (TF-TEG) and without (TEG) the addition of TF performed by 4 operators. Coagulation profiles (prothrombin time, activated partial thromboplastin time, platelet count, fibrinogen, antithrombin, and fibrinogen degradation products) were assessed in a subset of horses. Mean values (SD) for TEG parameters in healthy horses were: reaction time (R)=17.0 minutes (3.0 min), K time (K)=5.8 minutes (2.3 min), clotting rate (Ang)=42° (14°), maximum clot strength (maximum amplitude [MA])=60.3 mm (5.7 mm), CL30=97.0% (2.0%), LY30=0.8% (0.6%), CL60=92% (5.9%), LY60=3.2% (2.5%). Mean values (SD) for TF-TEG parameters were: R-TF=6.6 minutes (1.4 min), K-TF=3.1 minutes (1.0 min), Ang-TF=50.9° (9°), MA-TF=62.3 mm (5.1 mm), CL30-TF=97.8% (1.6%), LY30-TF=0.6% (0.5%), CL60-TF=90.8% (4.2%), and LY60-TF=3.6% (1.9%). The addition of TF decreased R and K and increased Ang. TF-TEG had a narrower SD for R, K, Ang, CL60 and LY60 compared with TEG. Interoperator differences were reduced by the addition of TF. Regression analysis indicated a positive relationship between MA and fibrinogen concentrations (P=0.02) and R-TF time and prothrombin time (P=0.03).

Conclusion – TF-TEG using the described protocol may minimize variability in data obtained across institutions or users. However, due to the variability associated with different operators, it is recommended that each laboratory set up individual reference intervals with the personnel who will perform the assay, and that the assay protocols and data obtained are compared on a regular basis.

Get access to the full text of this article

Ancillary